NFATc2 and NFATc3 regulate T(H)2 differentiation and modulate TCR-responsiveness of naïve T(H)cells - PubMed (original) (raw)
doi: 10.1038/ni744. Epub 2001 Dec 10.
Affiliations
- PMID: 11740499
- DOI: 10.1038/ni744
NFATc2 and NFATc3 regulate T(H)2 differentiation and modulate TCR-responsiveness of naïve T(H)cells
Jyothi Rengarajan et al. Nat Immunol. 2002 Jan.
Abstract
The NFAT family of transcription factors are key regulators of inducible gene expression in the immune system. We examined the function of two NFAT proteins after naïve T helper (T(H)) cell activation. We found that naïve T(H) precursors that are doubly deficient in NFATc2 and NFATc3 intrinsically differentiate into TH(2)-secreting cells, even in the absence of interleukin 4 (IL-4) production. We also found that lack of NFATc2 and NFATc3 obviates the necessity for engagement of CD28 on naïve cells and controls the time required to reach the first cell division upon activation. These results demonstrate a key role for NFATc2 and NFATc3 in modulating T cell receptor responsiveness and regulating subsequent cell division and T(H)2 differentiation.
Similar articles
- T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes.
Avni O, Lee D, Macian F, Szabo SJ, Glimcher LH, Rao A. Avni O, et al. Nat Immunol. 2002 Jul;3(7):643-51. doi: 10.1038/ni808. Epub 2002 Jun 10. Nat Immunol. 2002. PMID: 12055628 - The Runx1 transcription factor inhibits the differentiation of naive CD4+ T cells into the Th2 lineage by repressing GATA3 expression.
Komine O, Hayashi K, Natsume W, Watanabe T, Seki Y, Seki N, Yagi R, Sukzuki W, Tamauchi H, Hozumi K, Habu S, Kubo M, Satake M. Komine O, et al. J Exp Med. 2003 Jul 7;198(1):51-61. doi: 10.1084/jem.20021200. Epub 2003 Jun 30. J Exp Med. 2003. PMID: 12835475 Free PMC article. - Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N, Brossard M. Mejri N, et al. Int Immunol. 2007 Apr;19(4):535-43. doi: 10.1093/intimm/dxm019. Epub 2007 Mar 6. Int Immunol. 2007. PMID: 17344202 - The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H. Bian Y, et al. Int Immunol. 2005 Jan;17(1):73-83. doi: 10.1093/intimm/dxh188. Epub 2004 Nov 29. Int Immunol. 2005. PMID: 15569772 - Regulation of IL4 gene expression by T cells and therapeutic perspectives.
Li-Weber M, Krammer PH. Li-Weber M, et al. Nat Rev Immunol. 2003 Jul;3(7):534-43. doi: 10.1038/nri1128. Nat Rev Immunol. 2003. PMID: 12876556 Review.
Cited by
- The influence of HLA genetic variation on plasma protein expression.
Krishna C, Chiou J, Sakaue S, Kang JB, Christensen SM, Lee I, Aksit MA, Kim HI, von Schack D, Raychaudhuri S, Ziemek D, Hu X. Krishna C, et al. Nat Commun. 2024 Jul 31;15(1):6469. doi: 10.1038/s41467-024-50583-8. Nat Commun. 2024. PMID: 39085222 Free PMC article. - Overexpression of miR-490-5p/miR-490-3p Potentially Induces IL-17-Producing T Cells in Patients With Breast Cancer.
Seif F, Vaseghi H, Ariana M, Ganji SM, Nazari M, Rad KK, Pornour M. Seif F, et al. Eur J Breast Health. 2022 Apr 1;18(2):141-147. doi: 10.4274/ejbh.galenos.2022.2021-10-4. eCollection 2022 Apr. Eur J Breast Health. 2022. PMID: 35445179 Free PMC article. - High miR203a-3p and miR-375 expression in the airways of smokers with and without COPD.
van Nijnatten J, Brandsma CA, Steiling K, Hiemstra PS, Timens W, van den Berge M, Faiz A. van Nijnatten J, et al. Sci Rep. 2022 Apr 4;12(1):5610. doi: 10.1038/s41598-022-09093-0. Sci Rep. 2022. PMID: 35379844 Free PMC article. - CML derived exosomes promote tumor favorable functional performance in T cells.
Jafarzadeh N, Gholampour MA, Alivand MR, Kavousi S, Arzi L, Rad F, Sadeghizadeh M, Pornour M. Jafarzadeh N, et al. BMC Cancer. 2021 Sep 7;21(1):1002. doi: 10.1186/s12885-021-08734-3. BMC Cancer. 2021. PMID: 34493241 Free PMC article. - Role of NFAT in Chronic Lymphocytic Leukemia and Other B-Cell Malignancies.
Sana I, Mantione ME, Angelillo P, Muzio M. Sana I, et al. Front Oncol. 2021 Apr 1;11:651057. doi: 10.3389/fonc.2021.651057. eCollection 2021. Front Oncol. 2021. PMID: 33869054 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases